Concepts (57)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Absorbable Implants | 1 | 2017 | 6 | 0.600 |
Why?
|
| Everolimus | 1 | 2017 | 17 | 0.600 |
Why?
|
| Drug-Eluting Stents | 1 | 2017 | 48 | 0.570 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2017 | 72 | 0.540 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2017 | 151 | 0.510 |
Why?
|
| Postoperative Complications | 2 | 2020 | 1114 | 0.490 |
Why?
|
| Stellate Ganglion | 1 | 2024 | 5 | 0.240 |
Why?
|
| Metabolic Syndrome | 2 | 2017 | 148 | 0.240 |
Why?
|
| Cryosurgery | 1 | 2024 | 23 | 0.240 |
Why?
|
| Radiography, Interventional | 1 | 2024 | 66 | 0.230 |
Why?
|
| Tachycardia, Ventricular | 1 | 2024 | 117 | 0.210 |
Why?
|
| Mitral Valve Stenosis | 1 | 2020 | 11 | 0.180 |
Why?
|
| Prosthesis Failure | 1 | 2020 | 69 | 0.180 |
Why?
|
| Bioprosthesis | 1 | 2020 | 39 | 0.170 |
Why?
|
| Mitral Valve | 1 | 2020 | 101 | 0.170 |
Why?
|
| Heart Valve Prosthesis | 1 | 2020 | 86 | 0.160 |
Why?
|
| Thrombosis | 1 | 2020 | 193 | 0.150 |
Why?
|
| Sweden | 1 | 2017 | 40 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2024 | 1446 | 0.140 |
Why?
|
| Coronary Angiography | 1 | 2017 | 168 | 0.140 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 291 | 0.130 |
Why?
|
| Myocardium | 1 | 2017 | 261 | 0.130 |
Why?
|
| Survival Rate | 1 | 2017 | 783 | 0.130 |
Why?
|
| Ventricular Function, Right | 1 | 2015 | 27 | 0.120 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2015 | 47 | 0.120 |
Why?
|
| Polymers | 1 | 2017 | 315 | 0.120 |
Why?
|
| Incidence | 1 | 2017 | 1226 | 0.120 |
Why?
|
| Hypertension, Pulmonary | 1 | 2015 | 77 | 0.110 |
Why?
|
| Hemodynamics | 1 | 2015 | 216 | 0.110 |
Why?
|
| Ventricular Fibrillation | 1 | 2024 | 99 | 0.060 |
Why?
|
| Middle Aged | 4 | 2024 | 16127 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2024 | 5099 | 0.050 |
Why?
|
| Humans | 5 | 2024 | 58855 | 0.050 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2020 | 91 | 0.040 |
Why?
|
| Warfarin | 1 | 2020 | 108 | 0.040 |
Why?
|
| Male | 4 | 2024 | 27275 | 0.040 |
Why?
|
| Obesity | 2 | 2017 | 1178 | 0.040 |
Why?
|
| Cholesterol, HDL | 1 | 2017 | 77 | 0.040 |
Why?
|
| Risk Factors | 2 | 2017 | 4975 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2020 | 485 | 0.030 |
Why?
|
| Triglycerides | 1 | 2017 | 244 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 1441 | 0.030 |
Why?
|
| Echocardiography, Doppler, Pulsed | 1 | 2015 | 6 | 0.030 |
Why?
|
| Arterial Pressure | 1 | 2015 | 21 | 0.030 |
Why?
|
| Lipids | 1 | 2017 | 302 | 0.030 |
Why?
|
| Diastole | 1 | 2015 | 89 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2015 | 84 | 0.030 |
Why?
|
| Echocardiography | 1 | 2017 | 455 | 0.030 |
Why?
|
| Female | 3 | 2024 | 30564 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2017 | 890 | 0.030 |
Why?
|
| Ventricular Function, Left | 1 | 2015 | 262 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2024 | 5922 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2017 | 531 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 1020 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1048 | 0.020 |
Why?
|
| Adult | 2 | 2017 | 15602 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 13215 | 0.020 |
Why?
|